{"id":"https://openalex.org/W2005175682","doi":"https://doi.org/10.1186/1471-2334-14-s2-p83","title":"Boceprevir (BOC) and Telaprevir (TPV) therapeutic drug monitoring in HCV and HIV-HCV infected patients treated with triple therapy Ribavirine/Peg-interferon/Boceprevir or Telaprevir: impact of the antiretroviral (ARV) treatment","display_name":"Boceprevir (BOC) and Telaprevir (TPV) therapeutic drug monitoring in HCV and HIV-HCV infected patients treated with triple therapy Ribavirine/Peg-interferon/Boceprevir or Telaprevir: impact of the antiretroviral (ARV) treatment","alternate_titles":[],"publication_year":2014,"publication_date":"2014-05-01","ids":{"openalex":"https://openalex.org/W2005175682","doi":"https://doi.org/10.1186/1471-2334-14-s2-p83","mag":"2005175682","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4221026"},"language":"en","primary_location":{"id":"doi:10.1186/1471-2334-14-s2-p83","doi":"https://doi.org/10.1186/1471-2334-14-s2-p83","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1471-2334-14-s2-p83","pdf_url":"https://bmcinfectdis.biomedcentral.com/counter/pdf/10.1186/1471-2334-14-S2-P83","source":{"id":"https://openalex.org/S171015910","display_name":"BMC Infectious Diseases","issn_l":"1471-2334","issn":["1471-2334"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Infectious Diseases","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2005175682"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://bmcinfectdis.biomedcentral.com/counter/pdf/10.1186/1471-2334-14-S2-P83","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103430743","display_name":"AS Chantry","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162909","display_name":"H\u00f4pital de la Timone","ror":"https://ror.org/05jrr4320","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I21491767","https://openalex.org/I4210087487","https://openalex.org/I4210162909"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"AS Chantry","raw_affiliation_strings":["Pharmacokinetics and toxicology department, Timone Hospital, Marseille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacokinetics and toxicology department, Timone Hospital, Marseille, France","institution_ids":["https://openalex.org/I4210162909"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111161152","display_name":"Martine Tching-Sin","orcid":"https://orcid.org/0000-0003-0966-1836","observed_orcids":["https://orcid.org/0000-0003-0966-1836"]},"institutions":[{"id":"https://openalex.org/I4210162909","display_name":"H\u00f4pital de la Timone","ror":"https://ror.org/05jrr4320","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I21491767","https://openalex.org/I4210087487","https://openalex.org/I4210162909"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"M Tching-Sin","raw_affiliation_strings":["Pharmacokinetics and toxicology department, Timone Hospital, Marseille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacokinetics and toxicology department, Timone Hospital, Marseille, France","institution_ids":["https://openalex.org/I4210162909"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103185283","display_name":"Catherine Dhiver","orcid":"https://orcid.org/0000-0001-7168-8082","observed_orcids":["https://orcid.org/0000-0001-7168-8082"]},"institutions":[{"id":"https://openalex.org/I4210095915","display_name":"H\u00f4pital de la Conception","ror":"https://ror.org/00s7v8q53","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I21491767","https://openalex.org/I4210087487","https://openalex.org/I4210095915"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"C Dhiver","raw_affiliation_strings":["Infectious Diseases department, AP-HM Conception Hospital, Marseille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases department, AP-HM Conception Hospital, Marseille, France","institution_ids":["https://openalex.org/I4210095915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001595973","display_name":"Thierry All\u00e8gre","orcid":"https://orcid.org/0000-0001-9758-8514","observed_orcids":["https://orcid.org/0000-0001-9758-8514"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T Allegre","raw_affiliation_strings":["Hematology and Internal Medicine Department, Pays d\u2019Aix Hospital, Aix-en-Provence, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology and Internal Medicine Department, Pays d\u2019Aix Hospital, Aix-en-Provence, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"JM Ruiz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087487","display_name":"Assistance Publique H\u00f4pitaux de Marseille","ror":"https://ror.org/002cp4060","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I21491767","https://openalex.org/I4210087487"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"JM Ruiz","raw_affiliation_strings":["Medicine in prison department, AP-HM, H\u00f4pitaux Sud, Marseille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicine in prison department, AP-HM, H\u00f4pitaux Sud, Marseille, France","institution_ids":["https://openalex.org/I4210087487"]}]},{"author_position":"middle","author":{"id":null,"display_name":"A Assi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Assi","raw_affiliation_strings":["Infectiology department, Sainte Musse Hospital, Toulon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectiology department, Sainte Musse Hospital, Toulon, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044905145","display_name":"Danielle Botta\u2010Fridlund","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087487","display_name":"Assistance Publique H\u00f4pitaux de Marseille","ror":"https://ror.org/002cp4060","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I21491767","https://openalex.org/I4210087487"]},{"id":"https://openalex.org/I4210095915","display_name":"H\u00f4pital de la Conception","ror":"https://ror.org/00s7v8q53","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I21491767","https://openalex.org/I4210087487","https://openalex.org/I4210095915"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"D Botta-Fridlund","raw_affiliation_strings":["Digestive surgery department, AP-HM Conception Hospital, Marseille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Digestive surgery department, AP-HM Conception Hospital, Marseille, France","institution_ids":["https://openalex.org/I4210087487","https://openalex.org/I4210095915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027107191","display_name":"Philippe Halfon","orcid":"https://orcid.org/0000-0001-9350-837X","observed_orcids":["https://orcid.org/0000-0001-9350-837X"]},"institutions":[{"id":"https://openalex.org/I4210109141","display_name":"H\u00f4pital Europ\u00e9en","ror":"https://ror.org/01tfhsg94","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210109141"]},{"id":"https://openalex.org/I4210155579","display_name":"Alphabio","ror":"https://ror.org/05ry90052","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210155579"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"P Halfon","raw_affiliation_strings":["Alphabio Laboratory, Marseille, France","European Hospital, Marseille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alphabio Laboratory, Marseille, France","institution_ids":["https://openalex.org/I4210155579"]},{"raw_affiliation_string":"European Hospital, Marseille, France","institution_ids":["https://openalex.org/I4210109141"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037104733","display_name":"Olivia Faucher\u2010Zaegel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087487","display_name":"Assistance Publique H\u00f4pitaux de Marseille","ror":"https://ror.org/002cp4060","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I21491767","https://openalex.org/I4210087487"]},{"id":"https://openalex.org/I4210134195","display_name":"H\u00f4pital Sainte-Marguerite","ror":"https://ror.org/0338wkj94","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I21491767","https://openalex.org/I4210087487","https://openalex.org/I4210134195"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"O Faucher-Zaegel","raw_affiliation_strings":["Immuno-Hematology department, AP-HM Sainte-Marguerite Hospital, Marseille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immuno-Hematology department, AP-HM Sainte-Marguerite Hospital, Marseille, France","institution_ids":["https://openalex.org/I4210087487","https://openalex.org/I4210134195"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045396101","display_name":"Caroline Solas","orcid":"https://orcid.org/0000-0002-0943-9648","observed_orcids":["https://orcid.org/0000-0002-0943-9648"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I21491767","display_name":"Aix-Marseille Universit\u00e9","ror":"https://ror.org/035xkbk20","country_code":"FR","type":"education","lineage":["https://openalex.org/I21491767"]},{"id":"https://openalex.org/I4210162909","display_name":"H\u00f4pital de la Timone","ror":"https://ror.org/05jrr4320","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I21491767","https://openalex.org/I4210087487","https://openalex.org/I4210162909"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"C Solas","raw_affiliation_strings":["INSERM UMR 911 - CRO2, Faculty of Pharmacy, University of Aix-Marseille, Marseille, France","Pharmacokinetics and toxicology department, Timone Hospital, Marseille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM UMR 911 - CRO2, Faculty of Pharmacy, University of Aix-Marseille, Marseille, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I21491767"]},{"raw_affiliation_string":"Pharmacokinetics and toxicology department, Timone Hospital, Marseille, France","institution_ids":["https://openalex.org/I4210162909"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5103430743"],"corresponding_institution_ids":["https://openalex.org/I4210162909"],"apc_list":{"value":3090,"currency":"USD","value_usd":3090},"apc_paid":{"value":3090,"currency":"USD","value_usd":3090},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"14","issue":"S2","first_page":"83","last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/boceprevir","display_name":"boceprevir","score":0.9990000128746033},{"id":"https://openalex.org/keywords/telaprevir","display_name":"telaprevir","score":1.0},{"id":"https://openalex.org/keywords/therapeutic-drug-monitoring","display_name":"therapeutic drug monitoring","score":0.8370000123977661},{"id":"https://openalex.org/keywords/chronic-hepatitis-c","display_name":"chronic hepatitis C","score":0.8309999704360962},{"id":"https://openalex.org/keywords/hiv-hcv-coinfection","display_name":"HIV/HCV coinfection","score":0.9079999923706055},{"id":"https://openalex.org/keywords/ns3-4a-protease-inhibitors","display_name":"NS3/4A protease inhibitors","score":0.902999997138977},{"id":"https://openalex.org/keywords/ribavirin","display_name":"ribavirin","score":0.8920000195503235},{"id":"https://openalex.org/keywords/pegylated-interferon","display_name":"pegylated interferon","score":0.9020000100135803},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.8199999928474426},{"id":"https://openalex.org/keywords/multiple-drug-interactions","display_name":"multiple drug interactions","score":0.7599999904632568},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.824999988079071},{"id":"https://openalex.org/keywords/plasma-drug-concentration","display_name":"plasma drug concentration","score":0.6890000104904175},{"id":"https://openalex.org/keywords/lopinavir-ritonavir","display_name":"lopinavir/ritonavir","score":0.8849999904632568},{"id":"https://openalex.org/keywords/darunavir","display_name":"darunavir","score":0.8040000200271606},{"id":"https://openalex.org/keywords/efavirenz","display_name":"efavirenz","score":1.0}],"concepts":[{"id":"https://openalex.org/C2778159067","wikidata":"https://www.wikidata.org/wiki/Q408557","display_name":"Telaprevir","level":5,"score":0.9623354077339172},{"id":"https://openalex.org/C2777159539","wikidata":"https://www.wikidata.org/wiki/Q410551","display_name":"Boceprevir","level":5,"score":0.9600603580474854},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8041530847549438},{"id":"https://openalex.org/C2776979040","wikidata":"https://www.wikidata.org/wiki/Q5207712","display_name":"Daclatasvir","level":5,"score":0.7402123212814331},{"id":"https://openalex.org/C2779182219","wikidata":"https://www.wikidata.org/wiki/Q3765251","display_name":"Darunavir","level":5,"score":0.7103842496871948},{"id":"https://openalex.org/C2781432083","wikidata":"https://www.wikidata.org/wiki/Q422645","display_name":"Efavirenz","level":5,"score":0.5719214081764221},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.5613371729850769},{"id":"https://openalex.org/C2776461080","wikidata":"https://www.wikidata.org/wiki/Q7160835","display_name":"Pegylated interferon","level":5,"score":0.5455852746963501},{"id":"https://openalex.org/C2780040827","wikidata":"https://www.wikidata.org/wiki/Q421862","display_name":"Ribavirin","level":4,"score":0.4852275848388672},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.45942166447639465},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.454820454120636},{"id":"https://openalex.org/C2778986448","wikidata":"https://www.wikidata.org/wiki/Q7517689","display_name":"Simeprevir","level":5,"score":0.45085659623146057},{"id":"https://openalex.org/C2776408679","wikidata":"https://www.wikidata.org/wiki/Q708693","display_name":"Hepatitis C virus","level":3,"score":0.39861446619033813},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.2679896354675293},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.19398683309555054},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.18126830458641052},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.12982898950576782}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1186/1471-2334-14-s2-p83","doi":"https://doi.org/10.1186/1471-2334-14-s2-p83","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1471-2334-14-s2-p83","pdf_url":"https://bmcinfectdis.biomedcentral.com/counter/pdf/10.1186/1471-2334-14-S2-P83","source":{"id":"https://openalex.org/S171015910","display_name":"BMC Infectious Diseases","issn_l":"1471-2334","issn":["1471-2334"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Infectious Diseases","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3195195","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4221026","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:4221026","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4221026/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Infect Dis","raw_type":"Text"},{"id":"pmh:oai:HAL:inserm-00995738v1","doi":null,"is_oa":true,"landing_page_url":"https://inserm.hal.science/inserm-00995738","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"BMC Infectious Diseases, 2014, 14 (Suppl 2), pp.P83","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1186/1471-2334-14-s2-p83","doi":"https://doi.org/10.1186/1471-2334-14-s2-p83","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1471-2334-14-s2-p83","pdf_url":"https://bmcinfectdis.biomedcentral.com/counter/pdf/10.1186/1471-2334-14-S2-P83","source":{"id":"https://openalex.org/S171015910","display_name":"BMC Infectious Diseases","issn_l":"1471-2334","issn":["1471-2334"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Infectious Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2005175682.pdf","grobid_xml":"https://content.openalex.org/works/W2005175682.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2318745787","https://openalex.org/W2753437197","https://openalex.org/W2024345076","https://openalex.org/W151748315","https://openalex.org/W2154574897","https://openalex.org/W1991493420","https://openalex.org/W2142007317","https://openalex.org/W2063475714","https://openalex.org/W2051480405","https://openalex.org/W2094403606"],"abstract_inverted_index":{"BOC":[0,19,69],"and":[1,20,25,38,64,70,72],"TPV":[2,21,71],"are":[3,22],"potent":[4],"NS3/4A":[5],"protease":[6],"inhibitors":[7,27],"for":[8,54],"the":[9,29,73],"treatment":[10],"of":[11,28,62,76],"chronic":[12],"hepatitis":[13],"C":[14],"(HCV)":[15],"genotype":[16],"1":[17],"infection.":[18],"both":[23],"substrates":[24],"strong":[26],"CYP3A,":[30],"therefore":[31],"presenting":[32],"a":[33],"wide":[34],"interindividual":[35],"pharmacokinetic":[36],"variability":[37],"multiple":[39],"drug":[40],"interactions":[41],"especially":[42],"with":[43,68,79],"ARV":[44,56],"such":[45],"as":[46],"lopinavir/r,":[47],"darunavir/r":[48],"or":[49],"efavirenz,":[50],"thus":[51],"restricting":[52],"options":[53],"concomitant":[55],"therapy.":[57],"We":[58],"evaluated":[59],"plasma":[60],"concentrations":[61],"coinfected":[63],"monoinfected":[65],"patients":[66,77],"treated":[67,78],"PK":[74],"data":[75],"non":[80],"recommended":[81],"ARV.":[82]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2005175682","counts_by_year":[],"updated_date":"2026-11-13T13:42:25.865203","created_date":"2016-06-24T00:00:00"}
